Tuberculosis Overview

Tuberculosis (TB) is a contagious bacterial infection caused by Mycobacterium tuberculosis, primarily affecting the lungs but capable of spreading to other organs. TB remains a global public health challenge due to its persistent infection, drug resistance, and long treatment duration. The infection may be latent (inactive) or active, with active TB causing severe symptoms and being transmissible.

---

Tuberculosis Definition

TB is defined as a bacterial infection that:

• Affects the lungs (pulmonary TB) or other organs (extrapulmonary TB)
• Causes granuloma formation in affected tissues
• Impairs organ function if untreated
• Spreads through airborne droplets from infected individuals
• Can persist in latent form without symptoms

TB progression can be categorized into stages:

• Latent TB: Infection without symptoms, non-contagious
• Active TB: Symptomatic and contagious
• Drug-resistant TB: Resistant to standard antibiotics, requiring complex treatment

---

Types of Tuberculosis

TB can be categorized based on location, drug resistance, and clinical manifestation.

---

1. Pulmonary Tuberculosis

The most common form, affecting the lungs.

Symptoms:

• Persistent cough lasting more than 2–3 weeks
• Hemoptysis (coughing up blood)
• Chest pain
• Fever, night sweats
• Fatigue and weight loss

Pulmonary TB is highly contagious through respiratory droplets.

---

2. Extrapulmonary Tuberculosis

Affects organs outside the lungs, including:

• Lymph nodes (lymphatic TB)
• Bones and joints (skeletal TB)
• Kidneys and urinary tract (genitourinary TB)
• Brain and meninges (tuberculous meningitis)
• Liver, intestines, or peritoneum

Symptoms vary depending on organ involvement, often making diagnosis more complex.

---

3. Latent Tuberculosis Infection (LTBI)

• Occurs when TB bacteria remain dormant in the body
• No symptoms or contagiousness
• Can reactivate into active TB under weakened immunity

Screening and preventive treatment reduce the risk of progression.

---

4. Multidrug-Resistant TB (MDR-TB)

• Resistant to at least isoniazid and rifampin (first-line antibiotics)
• Develops due to incomplete treatment or drug-resistant strains
• Requires long-term, specialized antibiotic regimens
• Symptoms similar to pulmonary TB

---

5. Extensively Drug-Resistant TB (XDR-TB)

• Resistant to first-line and many second-line TB medications
• Very difficult to treat and associated with higher mortality
• Requires prolonged hospitalization and combination therapy

---

Causes and Risk Factors

TB occurs due to infection with Mycobacterium tuberculosis and is influenced by immune status and environmental factors.

Common Causes

• Inhalation of airborne droplets from an infected individual
• Close contact in crowded or poorly ventilated environments
• Reactivation of latent TB when immunity weakens

Risk Factors

• HIV infection or immunodeficiency
• Malnutrition
• Diabetes or chronic diseases
• Smoking and alcohol use
• Close contact with TB patients
• Living in areas with high TB prevalence
• Healthcare workers

---

Symptoms of Tuberculosis

Symptoms vary depending on TB type and stage.

Pulmonary TB Symptoms

• Persistent cough (>2–3 weeks)
• Coughing blood
• Chest pain
• Fatigue and weakness
• Fever, chills, and night sweats
• Weight loss and loss of appetite

Extrapulmonary TB Symptoms

• Swollen lymph nodes
• Bone or joint pain
• Headache or confusion (meningitis)
• Urinary symptoms (genitourinary TB)
• Abdominal pain (peritoneal TB)

Latent TB shows no symptoms but can reactivate later.

---

Diagnosis of Tuberculosis

Diagnosis involves clinical assessment, imaging, and laboratory tests.

Diagnostic Methods

• Medical history and symptom evaluation: risk factors and exposure
• Tuberculin Skin Test (TST): detects immune response to TB
• Interferon-Gamma Release Assays (IGRAs): blood test for latent TB
• Chest X-ray or CT scan: identifies lung lesions
• Sputum smear and culture: confirm active pulmonary TB
• Molecular tests (e.g., PCR): detect TB DNA and drug resistance

Early detection is critical for preventing spread and complications.

---

Treatment Options

TB treatment requires long-term antibiotic therapy.

---

1. First-Line Treatment

• Isoniazid
• Rifampin
• Ethambutol
• Pyrazinamide

Duration: 6–9 months depending on case severity.

---

2. Second-Line Treatment

• Used for MDR-TB or XDR-TB
• Includes fluoroquinolones, aminoglycosides, and newer antibiotics
• Requires longer duration and close monitoring for side effects

---

3. Supportive Measures

• Adequate nutrition
• Hydration
• Rest and immune support
• Avoiding smoking and alcohol
• Isolation precautions for contagious patients

---

4. Prevention of Tuberculosis

• Vaccination (BCG): provides partial protection, especially in children
• Early detection and treatment of latent TB
• Proper ventilation in crowded areas
• Use of masks and respiratory hygiene
• Regular screening for high-risk populations

---

Prognosis

• TB is curable with timely and complete treatment
• Drug-resistant TB has a more challenging prognosis
• Early intervention reduces transmission and complications
• Untreated active TB can be fatal

---

Advantages of Early Diagnosis

• Prevents transmission to others
• Ensures timely treatment
• Reduces risk of drug resistance
• Minimizes organ damage
• Improves overall survival rates

---

Disadvantages and Challenges

• Long treatment duration may affect compliance
• Drug-resistant TB requires complex regimens
• Late diagnosis increases risk of severe illness
• Requires strict monitoring for side effects
• Social stigma may prevent early reporting

---

Frequently Asked Questions (FAQ)

What causes tuberculosis?
Infection with Mycobacterium tuberculosis via airborne droplets.

Can TB be cured?
Yes, with complete antibiotic treatment. Drug-resistant forms require specialized therapy.

Is TB contagious?
Yes, especially active pulmonary TB.

Who is at risk for TB?
Immunocompromised individuals, close contacts, healthcare workers, and residents in high-prevalence regions.

Does BCG vaccine prevent TB?
It provides partial protection, mainly in children, but does not guarantee immunity.

How long is TB treatment?
Typically 6–9 months for drug-sensitive TB; longer for drug-resistant forms.

---

Conclusion

Tuberculosis (TB) is a serious infectious disease primarily affecting the lungs but capable of spreading to other organs. Early diagnosis, appropriate antibiotic treatment, supportive care, and preventive measures are essential for curing TB, preventing transmission, and reducing complications. Drug-resistant forms of TB require specialized management, highlighting the importance of adherence to treatment protocols and public health strategies.